PODD Stock Analysis: Buy, Sell, or Hold?
PODD - Insulet Corporation
$147.46
-1.22 (-0.82%)
▼
5d:
-4.35%
30d:
-26.81%
90d:
-39.25%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Accumulation
PODD is down 4.3% this week, but smart money is accumulating calls. Top strike: $170 2026-06-18 with 298 OI. Call ratio: 65% View Scanner →
Strength: 3.7/10
Get Alerted When PODD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PODD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PODD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$391.00
Based on 14.4% avg growth
INTRINSIC VALUE TODAY
$242.78
39.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PODD is currently trading at $147.46, which is considered oversold relative to its 30-day fair value range of $160.41 to $201.06. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.3) compared to its historical average (35.1). Remarkably, the market is currently pricing in an annual earnings decline of 19.6% over the next few years. This pessimistic expectation contrasts with the company's recent 159.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PODD is in a strong downtrend. The price is currently testing key support at $145.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PODD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $250.12 (+69.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PODD is in a strong downtrend. The price is currently testing key support at $145.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PODD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $250.12 (+69.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$160.41 -
$201.06
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding PODD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 69.6% below Wall St target ($250.12)
Trading Range Analysis
30-Day Trading Range
$160.41 -
$201.06
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$145.59
Resistance Level
$175.39
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.28
Wall Street Target
$250.13
(+69.6%)
Revenue Growth (YoY)
33.9%
Earnings Growth (YoY)
159.0%
Profit Margin
10.4%
Valuation Discount vs History
-19.6% cheaper
PE vs Historical
18.3 vs 35.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.6%
(market-implied from PE analysis)
1-Year Target
$132.71
(-10%)
2-Year Target
$119.44
(-19%)
3-Year Target
$107.50
(-27%)
3-Yr Target (if PE normalizes)
(PE: 18→35)
$206.37
(+40%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 24.8%)
$345.97
(+135%)
Base:
(SPY PE: 18.3, Growth: 24.8%)
$286.62
(+94%)
Bear:
(PE: 15.5, Growth: 24.8%)
$243.63
(+65%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 34.74 | Current EPS (TTM): $4.28
Bull Case
$308.18
(+109%)
Analyst growth 88.4%, PE expands to 38.2
Base Case
$280.16
(+90%)
Market implied 88.4%, PE stable at 34.7
Bear Case
$101.10
(-31%)
Severe decline -20.0%, PE contracts to 29.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.3 to 35.1
Stabilization Target:
$283.08
(+92.0%)
PE Expansion Potential:
+92.0%
Share & Embed Analysis
Last updated: May 18, 2026 3:18 AM ET
Data refreshes hourly during market hours. Next update: 4:18 AM
Data refreshes hourly during market hours. Next update: 4:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PODD showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael R Minogue
BUY
2030 shares
2026-02-25
Ro Khanna
SELL
2026-02-24
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 55 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 62 BUY |
Advanced PODD Option Strategies
Professional options setups generated by AI based on today's PODD price and gamma walls.
